rs863225234
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_153704.6(TMEM67):āc.2522A>Cā(p.Gln841Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000281 in 1,459,734 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_153704.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1459734Hom.: 0 Cov.: 29 AF XY: 0.0000303 AC XY: 22AN XY: 726318
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Joubert syndrome 6 Pathogenic:1
- -
not specified Uncertain:1
Variant summary: TMEM67 c.2522A>C (p.Gln841Pro) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 251162 control chromosomes (gnomAD). c.2522A>C has been reported in the literature in individuals affected with Joubert Syndrome And Related Disorders (Doherty_2010 and Suzuki_2016). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at